Literature DB >> 15365396

Diagnosis and treatment of ulcerative proctitis.

Miguel D Regueiro1.   

Abstract

Proctitis refers to inflammation of the rectum, a diagnosis made by endoscopic evaluation. Symptoms of proctitis include rectal bleeding, urgency, tenesmus, diarrhea or constipation, and occasionally rectal pain. The causes of proctitis include infection, medication, ischemia, radiation, and ulcerative proctitis. Ulcerative proctitis is an important and increasingly common subcategory of ulcerative colitis (UC) in which inflammation is limited to the rectum. Historically, oral aminosalicylates have been the mainstay of acute and maintenance therapy. A growing body of data, however, indicates that topical aminosalicylates are effective first line agents in ulcerative proctitis and distal UC. Topical aminosalicylates act more effectively and rapidly to induce and maintain remission compared with their oral counterparts or topical steroids. Rarely ulcerative proctitis is refractory to topical therapy and in these instances systemic corticosteroids, antibiotics, immunomodulators, or surgery is required. This review highlights the pathogenesis, diagnosis, and treatment of ulcerative proctitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365396     DOI: 10.1097/01.mcg.0000139178.33502.a3

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

1.  Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.

Authors:  Elangovan Gopal; Seiji Miyauchi; Pamela M Martin; Sudha Ananth; Penny Roon; Sylvia B Smith; Vadivel Ganapathy
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  [Lymphogranuloma venereum. An old disease in a new dress].

Authors:  M de Roche; M Sawatzki; L Degen; P Itin; U Flückiger; R Frei; D Goldenberger
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

Review 3.  Advances in sexually transmitted infections of the gastrointestinal tract.

Authors:  Siew C Ng; Brian Gazzard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-25       Impact factor: 46.802

4.  A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

Authors:  Mark Lamet
Journal:  Dig Dis Sci       Date:  2010-07-30       Impact factor: 3.199

5.  Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis.

Authors:  Ping-Chang Yang; Tao Liu; Bin-Quan Wang; Tao-Yuan Zhang; Zi-Yuan An; Peng-Yuan Zheng; Dao-Fa Tian
Journal:  BMC Gastroenterol       Date:  2005-09-06       Impact factor: 3.067

6.  Rhinosinusitis derived Staphylococcal enterotoxin B plays a possible role in pathogenesis of food allergy.

Authors:  Tao Liu; Bin-Quan Wang; Peng-Yuan Zheng; Shao-Heng He; Ping-Chang Yang
Journal:  BMC Gastroenterol       Date:  2006-08-18       Impact factor: 3.067

7.  Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis.

Authors:  Xiaojing Zhao; Changcheng Zhou; Jingjing Ma; Yunjuan Zhu; Min Sun; Peixue Wang; Yi Zhang; Haiqin Ma; Hongjie Zhang
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

8.  All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis.

Authors:  Xiangji Yan; Chunhua Yang; Mei Yang; Yana Ma; Yuanyuan Zhang; Yujie Zhang; Cui Liu; Qiuran Xu; Kangsheng Tu; Mingzhen Zhang
Journal:  J Nanobiotechnology       Date:  2022-03-02       Impact factor: 10.435

Review 9.  Colonoscopic evaluation in ulcerative colitis.

Authors:  Elizabeth R Paine
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-05-30

10.  Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.

Authors:  David T Rubin; William J Sandborn; Brian Bosworth; Salam Zakko; Glenn L Gordon; Mark E Sale; Robert L Rolleri; Pamela L Golden; Andrew C Barrett; Enoch Bortey; William P Forbes
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.